Safety and Efficacy of Stereotactic Radiosurgery in the Management of Primary Spinal Cord Glioblastoma: A Case Report

立体定向放射外科治疗原发性脊髓胶质母细胞瘤的安全性和有效性:病例报告

阅读:1

Abstract

OBJECTIVE: Primary spinal cord Glioblastoma multiforme (IV grade WHO), also known as Primary Spinal Cord Astrocytoma (SCA), accounts for 6-8% of primary spinal cord tumors and up to 1.5% of all spinal cord tumors. However, owing to their rarity, no large studies or management consensus are available. Gross total resection (GTR) is the best advisable approach; however, in primary spinal tumors, this procedure is not always safe or feasible. Higher radiation doses with conventional radiotherapy (RT) are limited by the spinal cord's radiation tolerance. Stereotactic radiosurgery (SRS) is an effective and safe alternative when administered with adequate real-time simulation and planning to minimize setup errors with risks to the normal spinal cord. CASE PRESENTATION: Herein we present the case of a 32-year-old woman with primary grade IV glioblastoma (GBM) of the spinal cord at cervical C3-C6 (C3-C6) vertebrae level who underwent subtotal resection. The patient presented with neurological impairment in the neck, shoulder, and limbs. Sphincteric dysfunction and hyperaesthesia on the chest were also recorded. As adjuvant therapy, SRS with a dose of 14 Gy to the PTV was administered, ensuring a Dmax of 12 Gy to the spinal cord. Patient was treated in the same day of simulation and planning; hence, no set-up discrepancies were recorded on Cone Beam CT (CBCT) images during the RT delivery. Two days after SRS, the patient's neurological symptoms improved with recovery of neck and shoulder motor functions followed by weak upper limb activity. Afterwards, 6 cycles of temozolomide were administered. CONCLUSION: We described a case of grade IV glioblastoma multiforme after partial resection, that was safely treated with adjuvant SRS in real-time with simulation and planning. This modality could improve the safety of SRS in the treatment of such tumors.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。